Application of Sendai virus

Language

Applications of Sendai virus vectors

We provide different F-defective Sendai virus vector products and customized packaging services for global scientific research institutions and biopharmaceutical enterprises.
We are looking for agency partners worldwide. If you are interested, please contact us by email. We can now provide test products for global customers. If you have any needs, please contact us.

F-defective Sendai virus vectors

Sendai virus has various natural advantages, including non-integrability, extremely high production titer, extremely high transgenic expression performance, significant target cell breadth, and no potential pathogenicity to humans.
We are committed to promoting our unique research and development of Fgene-defective Sendai virus vector technology to the world, including virus transformation into different types of products, and providing customized carrier packaging services for scientific research institutions and biopharmaceutical enterprises.

Application of Sendai virus-“Sendai virus-mediated RNA delivery restores fertility to congenital and chemotherapy-induced infertile female mice”

October 07,2024

The article discusses the research on the use of Sendai virus (SeV) for treating congenital and chemotherapy-induced infertility. The study shows that SeV successfully restores fertility in mice by enhancing KITL expression without the risk of viral gene integration. SeV therapy demonstrates potential for protecting fertility and offers new insights for future clinical applications.

About product supplementary description of (HVJ) MeltonVEC™-Cell Fusion Kit

October 03,2024

Our company produces the "MeltonVEC-Cell Fusion Kit", which operates on the same principle as the "GenomONE-CF EX" product. The cell fusion efficiency exceeds 75%, and the usage method is nearly identical. PBS can be used for dissolution.

Melton successfully completed the customization of F-defective Sendai virus samples for the CTSCB of the University of Hong Kong.

September 29,2024

Melton provides customized packaging F-defective Sendai virus service for CTSCB of the University of Hong Kong.

iPSC transduction tests on Human Fibroblast Cells

August 22,2024

Using MeltonVEC™-Sendai iPSC Reprogramming Kit (normal), human skin fibroblasts were subjected to transduction tests. It was found that the fibroblast cells were reprogrammed into iPSCs from Day 8. The typical iPSC morphology became very obvious under microscopic observation on Day 9.

About Us

Melton (Shenzhen) Biomedical Technology Company Limited makes use of the latest cutting-edge technologies in the field of life sciences to develop its core technology of the F-defective recombinant Sendai virus vectors, which have the advantages of ultra-high transfection efficiency and safety without integrating its genetic material into human chromosomes.

Melton's Mission
Our mission is committed to promoting recombinant Sendai virus vector technology to the world and contributing to the global healthcare sector.

About us: consectetur adipisc ing elit, sed do Eiusmod Tempor inci didunt ut labore et dolore

View More

Contact Us: Shenzhen City ,Guangdong Province, China +86; [email protected]; +86 755-84899046

Newsletter: Lorem ipsum dolor si consectetur adipisicing elit, sed eiusmotempor incididunt ut labore et

Follow Us